ArticleJournal for immunotherapy of cancer2023

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.

Dawei Rong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.